Dataset opportunity
Meridian Medical — 监管记录数据集机会
Meridian Medical 持有的中等监管记录数据集，可用于监管 RAG 和合规性 Copilots。
Score
47.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球监管信息管理市场 = 2024 年为 21.2 亿美元，复合年增长率为 10.41%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
监管记录数据集
Modality
文本
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
中等
Accessibility
部分
Legal
混合所有权 — 受限
Buyer persona
RegTech 和合规性 AI 供应商
Meridian Medical 持有专有的监管记录数据集，数据模态为文本，包含其合同制造业务的业务记录、工业数据和监管证明。这些结构化和非结构化数据，包括专有的工艺和验证信息，非常适合训练或微调监管 RAG 系统，以自动化和加强合规活动，例如回答监管查询和生成提交文件。
该数据所服务的全球监管信息管理市场在2024 年的估值为 21.2 亿美元，预计将以10.41% 的复合年增长率增长。尽管由于其作为 Kimal PLC 子公司的地位以及严格的 ISO 13485 要求而存在访问复杂性，但该数据集的价值仍然很高。这些障碍使得该数据成为一项稀有资产，因为专有的工艺和验证数据不易复制，为寻求构建专业监管工具的 AI 买家提供了独特的竞争优势。⚠ 尽职调查（有价值的数据，可协商的访问权限）：Kimal PLC 的子公司；决策可能在集团层面集中化；合同制造模式意味着部分设计知识产权属于客户，但工艺/验证数据是专有的；严格的医疗监管要求（ISO 13485）可能会在匿名化的情况下限制数据可移植性。· 公司：Kimal PLC 的子公司。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Meridian Medical 拥有详细的监管文件，包括具有完整可追溯性和验证数据的设计历史文件（DHF）。该数据集是寻求构建先进监管 RAG 系统的RegTech 和合规性 AI 供应商的主要资产。在全球监管信息市场年增长率超过 10%，总值超过 21.2 亿美元的情况下，这些数据提供了自动化复杂合规和提交流程所需的真实依据。
See dimension details ↓- Dataset Specificity78
主导的“监管”，医疗保健行业，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity46
专有领域数据（开放降低稀有度）
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness62
API/开放（当前）
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
适合监管 RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
高买家需求源于管理日益增长的监管复杂性的需求，这些解决方案的市场以 10.41% 的复合年增长率增长。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility52
开放/API 访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility51
中等难度，Kimal PLC 的子公司
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 种证据类型，4 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License32
所有权=混合，许可=受限
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
Kimal PLC 的子公司
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 个数据胃口信号（0 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ 审查 — 该公司是一家合同制造商，其核心业务是为其他公司生产医疗设备，而不是销售数据；然而，它持有的有价值的监管和生产数据很可能是其客户的知识产权，使其成为一个不合适的标的。问题：主要问题是数据所有权；作为一家合同制造商，他们制造的设备的设计、生产和监管数据几乎肯定属于客户；提供的 URL（meridian-medical.com）指向一家英国的合同制造商，但全球有许多其他独立的实体以“Meridian Medic”的名义运营。
- Deep Qualification80
✓ 通过 — Meridian Medical 是一个强大的数据持有者候选者。作为一家医疗设备合同制造商，它会生成大量的专有监管和工艺数据。然而，数据所有权与客户知识产权混合，并且由于法律文件无法访问，许可权未知，需要直接协商。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
这些证据表明持有者会生成结构化的营销材料，例如宣传册，这些材料可以为分析设备规格的 AI 模型提供有价值的产品背景。
Industrial data
这一信号表明存在来自制造运营的时间序列数据，证明持有者捕获了其洁净室组装的严格工艺监控信息。
Regulatory records
这是对核心数据集的直接确认，证明持有者拥有全面的监管记录，包括对训练合规性 AI 至关重要的关键设计历史文件（DHF）。
business_records
这些证据证实持有者管理和记录其复杂的供应链，为审计材料采购和组件可追溯性提供了丰富的记录来源。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Meridian Medical Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Regulatory Information Management Market = $2.12B in 2024, CAGR 10.41% (source: BlueWeave Consulting). Investment score 47.5/100 (confidence 0.56). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Hartmann International — API 可访问数据集机会
View opportunity →其他Listenfield — 搜索和查询日志数据集机会
View opportunity →其他Cruxbv — 法规记录数据集机会
View opportunity →